Hormone therapyPhase 3 trialInvestigational
Isturisa
Generic name: osilodrostat
How it works
Blocks the production of cortisol, a hormone that can promote cancer cell growth.
Cancer types
Leukemia— All patients
Efficacy
In clinical trials, around 70% of patients achieved a reduction in cortisol levels, with median progression-free survival of approximately 12 months.
Side effects
Moderate
Side effects can be significant and may require dose adjustments or supportive medication, but the treatment is usually continued.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.